Similar articles

• [Risks and benefits of influenza and pneumococcal immunization in HIV-1 infected individuals].

  Tanzi E, Amendola A, Zappa A, Pariani E, Monguzzi A, Colzani D. Tanzi E, et al. Ann Ig. 2003 Sep-Oct;15(5):567-73. Ann Ig. 2003. PMID: 14969311 Review. Italian.
• Editorial commentary: Perspectives on the role of immunization against influenza in HIV-infected patients.

  Dolin R. Dolin R. Clin Infect Dis. 2011 Jan 1;52(1):147-9. doi: 10.1093/cid/ciq017. Clin Infect Dis. 2011. PMID: 21148533 No abstract available.
• Safety, immunogenicity and shedding of LAIV4 in HIV-infected and uninfected children.

  Curtis D, Ning MF, Armon C, Li S, Weinberg A. Curtis D, et al. Vaccine. 2015 Sep 11;33(38):4790-7. doi: 10.1016/j.vaccine.2015.07.082. Epub 2015 Aug 1. Vaccine. 2015. PMID: 26241950
• Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children.

  King JC Jr, Fast PE, Zangwill KM, Weinberg GA, Wolff M, Yan L, Newman F, Belshe RB, Kovacs A, Deville JG, Jelonek M; HIV Influenza Study Group. King JC Jr, et al. Pediatr Infect Dis J. 2001 Dec;20(12):1124-31. doi: 10.1097/00006454-200112000-00006. Pediatr Infect Dis J. 2001. PMID: 11740317 Clinical Trial.
• Safety and immunogenicity of influenza vaccination in individuals infected with HIV.

  Zanetti AR, Amendola A, Besana S, Boschini A, Tanzi E. Zanetti AR, et al. Vaccine. 2002 Dec 20;20 Suppl 5:B29-32. doi: 10.1016/s0264-410x(02)00511-x. Vaccine. 2002. PMID: 12477415 Review.